Supplied in a dual-syringe Kit for easy administration, R-GEL is available in both a 2ml and a 4 ml dose.
Dr. Gar Royer, President and CEO of Royer Animal Health, commented: "We are very pleased to be entering into this relationship with MWI, and believe that many new practitioners, as well as their patients and clients will benefit from the positive outcomes that will result by using our innovative products."
Royer Animal Health, LLC has developed novel superior products utilizing proprietary drug delivery technologies. Our mission is to provide veterinary professional with localized drug delivery products providing increased drug concentration to the targeted site versus systemic delivery, and consequently enhanced efficacy, without systemic side effects. Both Matrix III and R-Gel drug delivery matrices, are bio-resorbable, and have the ability to provide an effective, controlled release of drugs over a broad range of time spans. For more information about Royer Animal Health, please visit our website at www.RoyerAH.com.
MWI is a distributor of animal health products to veterinarians across the United States. MWI sells pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment, supplies, veterinary pet food and nutritional products. They market these products to veterinarians in both the companion animal and production animal markets. For more information about MWI, please visit our website at www.mwivet.com.
For more information contact: Steve Kirschner at 301.696.2177
|SOURCE Royer Animal Health|
Copyright©2009 PR Newswire.
All rights reserved